Cuba Launches Phase II of Its 'Abdala' COVID-19 Vaccine
Cuba's Center for Genetic Engineering and Biotechnology (CIGB) General Director Marta Ayala Monday announced that Abdala COVID-19 vaccine (CIGB 66) started phase II of clinical trials, which will have around 760 volunteers.
Additional Info
- Countries Cuba
- Published in Health